saf-189s
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 28, 2015 (NCT04237805)
Timeline
Indications
Mechanism of action
- ALK tyrosine kinase receptorINHIBITOR
ALK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06569420 | Phase 3 | Dec 31, 2021 | Fosun |
| NCT04237805 | Phase 1/Phase 2 (Phase 2) | Sep 28, 2015 | Fosun |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fosun | For profit | 2 | 2 | 2 | 2015 |
1 organizations
Page 1 / 1